JP6463005B2 - マクロファージ識別剤、該マクロファージ識別剤を用いた識別方法、分取方法、評価方法、スクリーニング方法、およびキット - Google Patents

マクロファージ識別剤、該マクロファージ識別剤を用いた識別方法、分取方法、評価方法、スクリーニング方法、およびキット Download PDF

Info

Publication number
JP6463005B2
JP6463005B2 JP2014111593A JP2014111593A JP6463005B2 JP 6463005 B2 JP6463005 B2 JP 6463005B2 JP 2014111593 A JP2014111593 A JP 2014111593A JP 2014111593 A JP2014111593 A JP 2014111593A JP 6463005 B2 JP6463005 B2 JP 6463005B2
Authority
JP
Japan
Prior art keywords
group
subtype
macrophages
macrophage
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014111593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015006173A (ja
JP2015006173A5 (enExample
Inventor
史代 小出
史代 小出
野本　毅
毅 野本
幸子 山内
幸子 山内
渡邉　耕平
耕平 渡邉
太一 新藤
太一 新藤
健 宮▲崎▼
健 宮▲崎▼
田畑　泰彦
泰彦 田畑
恵理 三田
恵理 三田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canon Inc
Original Assignee
Canon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canon Inc filed Critical Canon Inc
Priority to JP2014111593A priority Critical patent/JP6463005B2/ja
Publication of JP2015006173A publication Critical patent/JP2015006173A/ja
Publication of JP2015006173A5 publication Critical patent/JP2015006173A5/ja
Application granted granted Critical
Publication of JP6463005B2 publication Critical patent/JP6463005B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ecology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2014111593A 2013-05-30 2014-05-29 マクロファージ識別剤、該マクロファージ識別剤を用いた識別方法、分取方法、評価方法、スクリーニング方法、およびキット Expired - Fee Related JP6463005B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014111593A JP6463005B2 (ja) 2013-05-30 2014-05-29 マクロファージ識別剤、該マクロファージ識別剤を用いた識別方法、分取方法、評価方法、スクリーニング方法、およびキット

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013114578 2013-05-30
JP2013114578 2013-05-30
JP2014111593A JP6463005B2 (ja) 2013-05-30 2014-05-29 マクロファージ識別剤、該マクロファージ識別剤を用いた識別方法、分取方法、評価方法、スクリーニング方法、およびキット

Publications (3)

Publication Number Publication Date
JP2015006173A JP2015006173A (ja) 2015-01-15
JP2015006173A5 JP2015006173A5 (enExample) 2017-07-06
JP6463005B2 true JP6463005B2 (ja) 2019-01-30

Family

ID=51988983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014111593A Expired - Fee Related JP6463005B2 (ja) 2013-05-30 2014-05-29 マクロファージ識別剤、該マクロファージ識別剤を用いた識別方法、分取方法、評価方法、スクリーニング方法、およびキット

Country Status (4)

Country Link
US (1) US10041937B2 (enExample)
EP (1) EP2943584B1 (enExample)
JP (1) JP6463005B2 (enExample)
WO (1) WO2014192972A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11519090B2 (en) * 2016-12-16 2022-12-06 Uacj Corporation Method and apparatus for producing electrolytic aluminum foil

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016203907A1 (ja) * 2015-06-16 2016-12-22 コニカミノルタ株式会社 画像処理装置、画像処理方法、および画像処理用のプログラム
AU2016362673A1 (en) 2015-12-01 2018-06-28 Dishman Carbogen Amcis Limited An improved process for the preparation of indocyanine green
CN106510745B (zh) * 2016-09-23 2021-06-01 东软医疗系统股份有限公司 Pet和ct/mri机械联动系统及其联动扫描方法
US10534097B2 (en) * 2016-10-14 2020-01-14 Shanghai United Imaging Healthcare Co., Ltd. Detector structure in a PET system
EP3553136A4 (en) * 2017-02-14 2020-03-11 Konica Minolta, Inc. AMINOCOUMARIN COMPOUND, AND RESIN PARTICLES WITH ENCAPSULATED AMINOCOUMARIN COMPOUND
JP7095603B2 (ja) * 2017-02-14 2022-07-05 コニカミノルタ株式会社 蛍光標識法
MX2020013416A (es) * 2019-03-01 2021-04-28 Illumina Cambridge Ltd Compuestos de coumarina sustituidos con amina terciaria y sus usos como etiquetas fluorescentes.
KR102550713B1 (ko) * 2021-01-18 2023-07-03 (주)바이오액츠 히드록시 치환된 트리아진을 포함하는 형광 화합물 및 이의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615878A (en) * 1980-03-12 1986-10-07 Lawrence Kass Metachromatic dye sorption means for differential determination of sub-populations of lymphocytes
US4803161A (en) * 1986-01-31 1989-02-07 Eastman Kodak Company Biological and analytical uses of phenalenone and benzphenalenone compounds
US20030157026A1 (en) 2001-06-27 2003-08-21 Katsuo Aizawa Photodynamic diagnosis and therapy for insulin-dependent diabetes mellitus
JP2003012547A (ja) 2001-06-27 2003-01-15 Meiji Seika Kaisha Ltd インスリン依存性糖尿病の診断剤および治療剤
SE0201750D0 (sv) * 2002-06-06 2002-06-06 Chalmers Technology Licensing Selective Chromophores
CA2641954C (en) * 2006-03-06 2016-04-26 Zetiq Technologies Ltd. Methods and compositions for identifying a cell phenotype
US20090258025A1 (en) * 2007-07-13 2009-10-15 Genentech, Inc. Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders
GB2463750A (en) 2008-07-15 2010-03-31 L3 Technology Ltd Assay device comprising surfaces of different surface energies
JP5538715B2 (ja) * 2008-12-25 2014-07-02 キヤノン株式会社 網膜組織染色組成物、網膜組織の染色方法
WO2010074325A1 (en) 2008-12-25 2010-07-01 Canon Kabushiki Kaisha Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
JP5733716B2 (ja) 2009-12-25 2015-06-10 キヤノン株式会社 中枢神経系組織標識用組成物、中枢神経系組織の標識方法、及び中枢神経系組織標識用組成物を用いたスクリーニング方法
WO2011077733A1 (ja) 2009-12-25 2011-06-30 キヤノン株式会社 経鼻中枢神経系組織標識用組成物、経鼻中枢神経系組織標識用組成物を用いた標識方法及びスクリーニング方法
US8753608B2 (en) 2010-08-24 2014-06-17 Canon Kabushiki Kaisha Complex and contrast agent for photoimaging using the same
JP5888904B2 (ja) 2011-02-16 2016-03-22 国立大学法人三重大学 中枢神経移行性評価用プローブ、中枢神経移行性評価方法、及び、中枢神経移行性評価用プローブを用いたスクリーニング方法
JP6057574B2 (ja) * 2012-07-11 2017-01-11 キヤノン株式会社 造血幹細胞識別用プローブ
WO2014065439A1 (en) 2012-10-26 2014-05-01 Canon Kabushiki Kaisha Cancer cell inhibitory drug and cancer stem-cell detection probe
WO2014065440A1 (en) 2012-10-26 2014-05-01 Canon Kabushiki Kaisha Cancer cell inhibitory drug and cancer stem-cell detection probe

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11519090B2 (en) * 2016-12-16 2022-12-06 Uacj Corporation Method and apparatus for producing electrolytic aluminum foil

Also Published As

Publication number Publication date
EP2943584B1 (en) 2019-08-14
US10041937B2 (en) 2018-08-07
US20160018389A1 (en) 2016-01-21
EP2943584A4 (en) 2016-06-29
WO2014192972A1 (en) 2014-12-04
EP2943584A1 (en) 2015-11-18
JP2015006173A (ja) 2015-01-15

Similar Documents

Publication Publication Date Title
JP6463005B2 (ja) マクロファージ識別剤、該マクロファージ識別剤を用いた識別方法、分取方法、評価方法、スクリーニング方法、およびキット
Liu et al. Ratiometric afterglow luminescent nanoplatform enables reliable quantification and molecular imaging
Gurram et al. Celecoxib conjugated fluorescent probe for identification and discrimination of cyclooxygenase-2 enzyme in cancer cells
Zhang et al. Fluorescence discrimination of cancer from inflammation by molecular response to COX-2 enzymes
Li et al. Detection of Aβ oligomers in early Alzheimer’s disease diagnose by in vivo NIR-II fluorescence imaging
CN103502465B (zh) 使用荧光标记了的l-葡萄糖衍生物检测癌细胞的方法以及含有该衍生物的癌细胞的显像剂
Lu et al. Responsive probes for in vivo magnetic resonance imaging of nitric oxide
Pei et al. Dual-functional AIE fluorescent probe for visualization of lipid droplets and photodynamic therapy of cancer
WO2011116142A1 (en) Method of using near infrared fluorescent dyes for imaging and targeting cancers
JP2014167119A (ja) ポリシクロ染料およびその使用
CN116768789A (zh) 一种聚集诱导发光自报告光敏剂探针及其制备方法与应用
Luo et al. Enhanced visualization of hematoxylin and eosin stained pathological characteristics by phasor approach
CN108245688A (zh) 肝细胞癌诊断试剂及其制备方法
Sun et al. A chemiluminescent reporter assisted by in-situ neutrophils for imaging O2− at inflammatory sites
JP6057574B2 (ja) 造血幹細胞識別用プローブ
Ramya et al. New insight of squaraine-based biocompatible surface-enhanced Raman scattering nanotag for cancer-cell imaging
Chen et al. Near‐infrared II fluorescence imaging highlights tumor angiogenesis in hepatocellular carcinoma with a VEGFR‐targeted probe
Li et al. NIR-II Ratiometric Fluorescence Probes Enable Precise Determination of the Metastatic Status of Sentinel Lymph Nodes
Zhang et al. Real‐time monitoring of small extracellular vesicles (sEVs) by in vivo flow cytometry
CN113735839A (zh) 二氢呫吨/苯并[cd]吲哚杂合物荧光探针及其制备方法与应用
WO2025039363A1 (zh) 一种近红外两性离子花菁染料及其制备方法和应用
CN109796444B (zh) 一种近红外双荧光探针化合物及制法和应用
CN114315643B (zh) 一种靶向脂滴和水环境的双色荧光探针及其合成方法和应用
CN102706787B (zh) 菁染料的新用途
Dai et al. Decreased lysosomal polarity during acute alcoholic liver injury revealed by a near-infrared fluorescent probe

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150910

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170522

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170522

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7425

Effective date: 20171214

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20180126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180508

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181204

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181228

R151 Written notification of patent or utility model registration

Ref document number: 6463005

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

LAPS Cancellation because of no payment of annual fees